Comparative systematic genetics for cardiovascular disease gene identification

Information

  • Research Project
  • 7156592
  • ApplicationId
    7156592
  • Core Project Number
    R41HL083571
  • Full Project Number
    1R41HL083571-01A1
  • Serial Number
    83571
  • FOA Number
    PA-06-07
  • Sub Project Id
  • Project Start Date
    8/15/2006 - 18 years ago
  • Project End Date
    7/31/2008 - 16 years ago
  • Program Officer Name
    PALTOO, DINA
  • Budget Start Date
    8/15/2006 - 18 years ago
  • Budget End Date
    7/31/2008 - 16 years ago
  • Fiscal Year
    2006
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    8/10/2006 - 18 years ago
Organizations

Comparative systematic genetics for cardiovascular disease gene identification

[unreadable] DESCRIPTION (provided by applicant): This proposal will lead to identification of gene variants that increase the risk of developing cardiovascular disease. The underlying hypothesis is that systematic genetics conducted in model organisms enables the identification of disease-specific gene modules. This hypothesis will be tested in Phase I through the following Aims: (1) Create a database of phenotypes observed in systematic genetic screens conducted in yeast, worm, fly, zebrafish, and other model organisms. (2) Develop and apply data mining algorithms to identify modules of genes whose deletion or silencing phentoypes show similar patterns across model organisms. (3) Identify modules that are enriched for genes with known variants relevant to cardiovascular disease. Other genes in these modules will then be candidate genes for variants conferring cardiovascular disease risk or can be used to improve priors for whole-genome association tests. In Phase II, variants of candidate genes will be genotyped across a cardiovascular patient population with the goal of identifying genetic markers to assist in diagnosis and treatment of cardiovascular disease. If successful, this proposal will lead to genetic tests that will improve the clinical treatment of patients at risk for cardiovascular disease. The comparative systematic genetics platform developed will be broadly applicable to identifying gene modules relevant to other human diseases and will extend to systematic genetics data collected for a growing set of model organisms. [unreadable] [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R41
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    182732
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:182732\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    OMICIA, INC.
  • Organization Department
  • Organization DUNS
    148382315
  • Organization City
    EMERYVILLE
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94608
  • Organization District
    UNITED STATES